Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. STAAR Surgical Company
  6. Summary
    STAA   US8523123052

STAAR SURGICAL COMPANY

(STAA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/09/2022 05/10/2022 05/11/2022 05/12/2022 05/13/2022 Date
55.08(c) 52.83(c) 50.24(c) 54.19(c) 58.18(c) Last
1 096 396 854 985 726 301 915 434 601 021 Volume
-10.31% -4.08% -4.90% +7.86% +7.36% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 296 M - -
Net income 2022 30,9 M - -
Net Debt 2022 - - -
P/E ratio 2022 93,3x
Yield 2022 -
Sales 2023 374 M - -
Net income 2023 53,9 M - -
Net Debt 2023 - - -
P/E ratio 2023 53,2x
Yield 2023 -
Capitalization 2 781 M 2 781 M -
Capi. / Sales 2022 9,40x
Capi. / Sales 2023 7,44x
Nbr of Employees 697
Free-Float 99,6%
More Financials
Company
STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom and Singapore, with a... 
Read more
More about the company
Ratings of STAAR Surgical Company
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about STAAR SURGICAL COMPANY
05/06STAAR SURGICAL CO : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
05/04STAAR SURGICAL : Q1 Earnings Snapshot
AQ
05/04STAAR Surgical Posts Higher Q1 Results Beating Street Views
MT
05/04TRANSCRIPT : STAAR Surgical Company, Q1 2022 Earnings Call, May 04, 2022
CI
05/04STAAR SURGICAL CO MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
05/04STAAR Surgical Company Reports Earnings Results for the First Quarter Ended April 01, 2..
CI
05/04STAAR Surgical Company Provides Earnings Guidance for the Full Year of 2022
CI
05/04Earnings Flash (STAA) STAAR SURGICAL COMPANY Reports Q1 Revenue $63.2M, vs. Street Est ..
MT
05/04Earnings Flash (STAA) STAAR SURGICAL COMPANY Posts Q1 EPS $0.29, vs. Street Est of $0.1..
MT
05/04STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y
BU
04/26Canaccord Genuity Adjusts STAAR Surgical's Price Target to $89 from $81, Keeps Buy Rati..
MT
04/20STAAR Surgical to Report First Quarter Results on May 4, 2022
BU
04/08Needham Starts STAAR Surgical at Buy With $87 Price Target, Citing 'Clear View Into Dur..
MT
04/06SECTOR UPDATE : Health Care Stocks Decline Premarket Wednesday
MT
04/06STAAR Surgical Reports First Implants of EVO Visian Lens in US
MT
More news
News in other languages on STAAR SURGICAL COMPANY
05/04STAAR Surgical affiche des résultats plus élevés au 1er trimestre, dépassant les prévis..
05/04STAAR Surgical Company annonce ses résultats pour le premier trimestre clos le 01 avril..
05/04STAAR Surgical Company fournit des prévisions de bénéfices pour l'année complète de 202..
05/04Earnings Flash (STAA) STAAR SURGICAL COMPANY annonce un chiffre d'affaires de 63,2 mill..
04/06MISE À JOUR SECTORIELLE : Les actions du secteur de la santé chutent mercredi avant le mar..
More news
Analyst Recommendations on STAAR SURGICAL COMPANY
More recommendations
Chart STAAR SURGICAL COMPANY
Duration : Period :
STAAR Surgical Company Technical Analysis Chart | STAA | US8523123052 | MarketScreener
Technical analysis trends STAAR SURGICAL COMPANY
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 58,18 $
Average target price 101,00 $
Spread / Average Target 73,6%
EPS Revisions
Managers and Directors
Caren L. Mason Director
Patrick F. Williams Chief Financial Officer & Vice President
Louis E. Silverman Chairman
Keith Holliday Chief Technology Officer
Scott D. Barnes Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
STAAR SURGICAL COMPANY-36.28%2 781
ABBOTT LABORATORIES-21.93%192 394
MEDTRONIC PLC-0.75%137 736
BECTON, DICKINSON AND COMPANY1.09%70 821
BAXTER INTERNATIONAL INC.-14.92%36 773
HOYA CORPORATION-26.45%35 552